|
US3311628A
(en)
*
|
1965-03-09 |
1967-03-28 |
Bristol Myers Co |
Derivatives of pyrrolo [2, 3-d] pyrimidine
|
|
CH592668A5
(OSRAM)
*
|
1973-10-02 |
1977-10-31 |
Delalande Sa |
|
|
DK0682027T3
(da)
*
|
1994-05-03 |
1998-05-04 |
Ciba Geigy Ag |
Pyrrolopyrimidinderivater med antiproliferativ virkning
|
|
US6878716B1
(en)
|
1998-06-02 |
2005-04-12 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A1 receptor and uses thereof
|
|
US6686366B1
(en)
|
1998-06-02 |
2004-02-03 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A3 receptor and uses thereof
|
|
JP4611524B2
(ja)
|
1998-06-02 |
2011-01-12 |
オーエスアイ・ファーマスーティカルズ・インコーポレーテッド |
ピロロ［２，３ｄ］ピリミジン組成物およびその使用
|
|
RS50087B
(sr)
*
|
1998-06-19 |
2009-01-22 |
Pfizer Products Inc., |
Pirolo (2,3-d) pirimidin jedinjenja
|
|
PA8474101A1
(es)
|
1998-06-19 |
2000-09-29 |
Pfizer Prod Inc |
Compuestos de pirrolo [2,3-d] pirimidina
|
|
US7160890B2
(en)
|
1999-12-02 |
2007-01-09 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A3 receptor and uses thereof
|
|
US6680322B2
(en)
|
1999-12-02 |
2004-01-20 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A1 receptors and uses thereof
|
|
US6664252B2
(en)
|
1999-12-02 |
2003-12-16 |
Osi Pharmaceuticals, Inc. |
4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
|
|
CZ303875B6
(cs)
|
1999-12-10 |
2013-06-05 |
Pfizer Products Inc. |
Pyrrolo[2,3-d]pyrimidinová sloucenina a farmaceutická kompozice s jejím obsahem
|
|
US6673802B2
(en)
|
2000-12-01 |
2004-01-06 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A3 receptor and uses thereof
|
|
US6680324B2
(en)
|
2000-12-01 |
2004-01-20 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A1 receptors and uses thereof
|
|
DE10148883A1
(de)
*
|
2001-10-04 |
2003-04-10 |
Merck Patent Gmbh |
Pyrimidinderivate
|
|
ATE446298T1
(de)
|
2001-11-30 |
2009-11-15 |
Osi Pharm Inc |
Verbindungen, die für adenosin a1 und a3 rezeptoren spezifisch sind, und deren anwendungen
|
|
AU2002366811B2
(en)
|
2001-12-20 |
2009-01-15 |
Osi Pharmaceuticals, Inc. |
Pyrimidine A2B selective antagonist compounds, their synthesis and use
|
|
CN1816551A
(zh)
|
2001-12-20 |
2006-08-09 |
Osi药物公司 |
吡咯并嘧啶A2b选择性拮抗剂化合物,它们的合成及用途
|
|
CA2507392A1
(en)
|
2002-11-26 |
2004-06-10 |
Pfizer Products Inc. |
Method of treatment of transplant rejection
|
|
EP1979353A2
(en)
*
|
2006-01-19 |
2008-10-15 |
OSI Pharmaceuticals, Inc. |
Fused heterobicyclic kinase inhibitors
|
|
PT2384326E
(pt)
|
2008-08-20 |
2014-06-09 |
Zoetis Llc |
Compostos de pirrolo[2,3-d]pirimidina
|
|
NL2022471B1
(en)
|
2019-01-29 |
2020-08-18 |
Vationpharma B V |
Solid state forms of oclacitinib
|